Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT05322330 · COMPLETED
Trial details
- NCT number
- NCT05322330
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2024-02-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.